DE602006017703D1 - Zusammensetzungen und verfahren in verbindung mit orthogonalen ribosomen-mrna-paaren - Google Patents

Zusammensetzungen und verfahren in verbindung mit orthogonalen ribosomen-mrna-paaren

Info

Publication number
DE602006017703D1
DE602006017703D1 DE602006017703T DE602006017703T DE602006017703D1 DE 602006017703 D1 DE602006017703 D1 DE 602006017703D1 DE 602006017703 T DE602006017703 T DE 602006017703T DE 602006017703 T DE602006017703 T DE 602006017703T DE 602006017703 D1 DE602006017703 D1 DE 602006017703D1
Authority
DE
Germany
Prior art keywords
orthogonal
compositions
methods related
orthogonal ribosome
mrna pairs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006017703T
Other languages
English (en)
Inventor
Oliver Rackham
Jason W Chin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of DE602006017703D1 publication Critical patent/DE602006017703D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DE602006017703T 2005-07-15 2006-07-14 Zusammensetzungen und verfahren in verbindung mit orthogonalen ribosomen-mrna-paaren Active DE602006017703D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69993605P 2005-07-15 2005-07-15
PCT/GB2006/002637 WO2007010221A2 (en) 2005-07-15 2006-07-14 COMPOSITIONS AND METHODS RELATING TO ORTHOGONAL RIBOSOME mRNA PAIRS

Publications (1)

Publication Number Publication Date
DE602006017703D1 true DE602006017703D1 (de) 2010-12-02

Family

ID=37517116

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006017703T Active DE602006017703D1 (de) 2005-07-15 2006-07-14 Zusammensetzungen und verfahren in verbindung mit orthogonalen ribosomen-mrna-paaren

Country Status (9)

Country Link
US (2) US7888293B2 (de)
EP (2) EP2361979A3 (de)
JP (1) JP5213706B2 (de)
AT (1) ATE485376T1 (de)
AU (1) AU2006271503B2 (de)
CA (2) CA2614326C (de)
DE (1) DE602006017703D1 (de)
DK (1) DK1907545T3 (de)
WO (1) WO2007010221A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2614326C (en) * 2005-07-15 2012-09-18 Medical Research Council Compositions and methods relating to orthogonal ribosome mrna pairs
GB0623974D0 (en) 2006-11-30 2007-01-10 Medical Res Council Evolved orthogonal ribosomes
WO2021011524A1 (en) * 2019-07-14 2021-01-21 The Broad Institute, Inc. Heterologous ribosome generation, assessment and compositions thereof
WO2024033446A1 (en) * 2022-08-09 2024-02-15 Geg Tech Transient expression system for rna, for gene editing
WO2024033441A1 (en) * 2022-08-09 2024-02-15 Geg Tech Transient expression system for rna
WO2024033448A1 (en) * 2022-08-09 2024-02-15 Geg Tech Transient expression system for rna, for vaccination
WO2024033444A1 (en) * 2022-08-09 2024-02-15 Geg Tech Transient expression system for rna, for cosmetic uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6953394A (en) * 1993-05-21 1994-12-20 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
MXPA03009563A (es) * 2001-04-19 2004-12-06 Scripps Research Inst Incorporacion in vivo de aminoacidos no naturales.
CA2614326C (en) * 2005-07-15 2012-09-18 Medical Research Council Compositions and methods relating to orthogonal ribosome mrna pairs

Also Published As

Publication number Publication date
DK1907545T3 (da) 2011-02-07
US20110143418A1 (en) 2011-06-16
US20090048434A1 (en) 2009-02-19
EP1907545A2 (de) 2008-04-09
AU2006271503B2 (en) 2012-06-07
WO2007010221A3 (en) 2007-06-07
EP2361979A2 (de) 2011-08-31
EP2361979A3 (de) 2011-11-09
EP1907545B1 (de) 2010-10-20
CA2782619A1 (en) 2007-01-25
AU2006271503A1 (en) 2007-01-25
ATE485376T1 (de) 2010-11-15
CA2614326C (en) 2012-09-18
JP5213706B2 (ja) 2013-06-19
US7888293B2 (en) 2011-02-15
CA2614326A1 (en) 2007-01-25
JP2009501019A (ja) 2009-01-15
WO2007010221A2 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
DE602006017703D1 (de) Zusammensetzungen und verfahren in verbindung mit orthogonalen ribosomen-mrna-paaren
DE602005011594D1 (de) Azeotropartige trifluoriodmethanzusammensetzungen
MY158385A (en) Foaming agents and compositions containing fluorine substituted olefins, and methods of foaming
DE602005014628D1 (de) Embolie-teilchen
CR9360A (es) Composiciones de herbicidas que contienen limoneno, formulaciones de concentrados de herbicidas y metodos para fabricar y usar las mismas.
ATE407967T1 (de) Nukleierungsmittel
ATE518905T1 (de) Blasmittelzusammensetzung aus hydrofluorpropen und hydrochlorfluorolefin
ATE483463T1 (de) Pyridonsulfonamide und pyridonsulfamide als mek- hemmer
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
ATE471324T1 (de) Triazolophthalazine
WO2010111576A3 (en) Aminated polymers and their use in water-borne compositions
DK3524657T3 (da) Sammensætninger omfattende hfc-1234yf og hfc-32
WO2006015258A3 (en) Methods and compositions related to argonaute proteins
DE602005027222D1 (de) Schaumbare zusammensetzung
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
NO20091520L (no) Skummende blandinger og fremgangsmåter for fremstilling av disse
DE602006006950D1 (de) Zusammensetzungen, Verwendungen und Kit für die Behandlung von Dermatitis
CY1111762T1 (el) Διενυδρη παμοϊκη ολανζαπiνη
EA200601855A1 (ru) Гербицидоактивные 3-амино-2-тиометилбензоилпиразолы
WO2006075012A3 (en) Pyrrolodihydroisoquinolines as antiproliferative agents
DK1971608T3 (da) Spiroketaler
DE602005024251D1 (de) Fluoriertes polyetherpolyamin und herstellungsverfahren dafür
DE502006007287D1 (de) N von werkstücken
MX2017015302A (es) Agentes nucleosidos para la reduccion de la actividad perjudicial de los genes que contienen repeticiones de nucleotidos extendidas.
DE602006006777D1 (de) Zusammensetzung und damit zusammenhängender Prozess